AzTrials
AzTrials

End-stage Renal DiseaseNCT05255757

Network Interventions to Reduce Disparities in Living Kidney Donation

A study testing Script Intervention and Search Intervention in people with End-stage Renal Disease, run by Penn State University at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

For this current phase of the larger project, the investigators will survey transplant candidates as well as the participants family and friends to understand the barriers to volunteering and evaluation. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
End-stage Renal Disease
What is being tested?
Script Intervention and Search Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
164 participants
Where
2 sitesUnited States
Study dates
12 Oct 2021to 31 May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Are KT candidates at the University of Pennsylvania or University of Alabama-Birmingham OR were identified by KT candidate from the University of Pennsylvania or University of Alabama-Birmingham as a network member
  • Are adults aged 18 or older
  • Are able and willing to consent to participation in the survey

Who cannot join

  • Person is not a KT candidate at University of Pennsylvania or University of Alabama-Birmingham OR was NOT identified by KT candidate from University of Pennsylvania or University of Alabama-Birmingham as a network member
  • Individuals who are not yet 18
  • Participant does not speak English

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • University of Alabama-Birmingham

    Birmingham, Alabama, 35233

  • Penn Medicine-- University of Pennsylvania

    Philadelphia, Pennsylvania, 19104

Other trials in United States

About this study

Official title: Social Network Interventions to Reduce Race Disparities in Living Kidney Donation

For this current phase of the larger project, the investigators will survey transplant candidates as well as the participants family and friends to understand the barriers to volunteering and evaluation. This project will examine how network characteristics are associated with eventual living donor kidney transplant outcomes and test the efficacy of evidence-based interventions designed to assist kidney transplant candidates in participant donor search on a multi-center scale.

Read the detailed description

The overall goal is to understand the process and assist participants who do not receive unsolicited offers to be evaluated as a living kidney donor in initiating and effectively conducting these critical conversations with participants kin and friends. In the search intervention, based on what they can tell investigators about the number, type, perceived health, perceived relationship, and potential willingness to donate, as well as analyses of data from the National Health and Nutrition Examination Survey (NHANES) investigators will counsel them on which members of participants family and friendship networks appear most biomedically promising as donors among the subset of these individuals that participants have not ruled out for known medical or perceived relationship reasons. In the rhetorical intervention, investigators will test non-coercive, promising verbal scripts that have proven promising in preliminary tests in vignette experiments in online and phone surveys.

AIM 1: Survey transplant candidates about their social network and transplant-related attitudes, knowledge, and characteristics; and randomize participants into one of two interventions or a control group.

AIM 2: Send network member participants a survey that measures potential donor attributes that are hypothesized to influence donation decisions, such as medical contraindications, blood type, health insurance status, and barriers to living donation.

AIM 3: Test whether participant social networks and interventions affect donation outcomes using medical records and follow-ups provided by Penn and UAB. Investigators will create the first predictive model of potential donor evaluation and actual donation. This information is critical to improve clinical practice and efforts to ethically influence the living donor search process.

Being tested
Script Intervention, Search Intervention
Medical subject headings
Kidney Failure, Chronic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Script InterventionBehavioural

    This intervention provides language to participants to allow them to discuss kidney transplantation with their social network.

  • Search InterventionBehavioural

    This group will complete the candidate survey, refer members of their family and social network for participation in a web survey, and be given information about the statistical likelihood that each member of their social network will be free of contraindications for living kidney donation.

Study groups in NCT05255757
Study groupRoleWhat they receive
No interventionNo interventionThis group will only complete study survey and refer members of their family and social network for participation in a web survey.
Script InterventionExperimentalThis group will complete the survey, refer members of their family and social network for participation in a web survey, and review a set of suggested talking points and an example script to guide discussion of potential living donation with members of their network.
Receives: Behavioral: Script Intervention
Search InterventionExperimentalThis group will complete the candidate survey, refer members of their family and social network for participation in a web survey, and be given information about the statistical likelihood that each member of their social network will be free of contraindications for living kidney donation.
Receives: Behavioral: Search Intervention
Both Search and Script InterventionExperimentalThis group will complete the candidate survey, refer members of their family and social network for participation in a web survey, be given information about the statistical likelihood that each member of their social network will be free of contraindications for living kidney donation, and review a set of suggested talking points and an example script to guide discussion of potential living donation with members of their network.
Receives: Behavioral: Script Intervention; Behavioral: Search Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Received a living donor kidney transplant

    Living donor kidney transplant received by patient

    Measured: up to 3 years

  2. Received a deceased donor kidney transplant

    Deceased donor kidney transplant received by patient

    Measured: up to 3 years

  3. Death

    Patient died during the follow-up period

    Measured: up to 3 years

  4. Completed living kidney donor screening questionnaires

    Number of completed living kidney donation screening questionnaires completed for patient

    Measured: up to 3 years

  5. Preliminary approval from living kidney donor screening questionnaires

    Number of completed living kidney donor screening that received preliminary approval for patient

    Measured: up to 3 years

  6. Completed living kidney donor evaluations

    Number of living kidney donor evaluations completed for patient

    Measured: up to 3 years

  7. Approvals for living kidney donor candidacy

    Number of completed living kidney donor evaluations that resulted in approved living kidney donor candidacy for patient

    Measured: up to 3 years

Secondary outcomes (6)
  1. Preference for living kidney donor

    A set of survey questions asked both before and after the intervention, to assess intermediate attitude outcomes regarding preference for living kidney donor

    Measured: Immediate

  2. Concerns about living kidney donation

    A set of survey questions asked both before and after the intervention, to assess intermediate attitude outcomes regarding concerns for living kidney donation

    Measured: Immediate

  3. Living donor kidney transplant willingness

    A set of survey questions asked both before and after the intervention, to assess intermediate attitude outcomes regarding living donor kidney transplant willingness

    Measured: Immediate

  4. Self-rated kidney transplant knowledge

    Respondent is asked to rate their level of knowledge related to kidney transplantation.

    Measured: Immediate

  5. Trust in medical institutions

    Respondent is asked to rate their trust in medical institutions.

    Measured: Immediate

  6. Religious views' effect on kidney transplant willingness

    Respondent is asked how strongly they agree that their religious views affect their willingness to pursue a kidney transplant.

    Measured: Immediate

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Feb 2022
  2. Study start12 Oct 2021
  3. Primary completion31 May 2024
  4. Study completion31 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Factorial
Model description
There are two interventions randomly assigned to participants in a factorial experimental design. The first intervention is the search intervention. In addition to the candidate survey, transplant candidates assigned to this intervention will be given information about the statistical likelihood that each member of their social network will be free of contraindications for living kidney donation. The second intervention is the script intervention, where in addition to the survey, transplant candidates will review a set of suggested talking points and an example script to guide discussion of potential living donation with members of their network. 25% of participants will be assigned to each of the following factorial experimental groups: no intervention, search intervention only, script intervention only, or both search and script intervention.
Masking
None (open label)
Enrolment
164 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05255757
Sponsor's protocol ID
849197
Status last verified
Oct 2024
First submitted
10 Oct 2021
Last updated
24 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Script Intervention and Search Intervention in people with End-stage Renal Disease, run by Penn State University at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Received a living donor kidney transplant (time frame: up to 3 years). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in